Advertisement

The Scientist

» ebola and developmental biology

Most Recent

image: Science Setbacks: 2014

Science Setbacks: 2014

By | December 25, 2014

This year in life science was marked by paltry federal funding increases, revelations of sequence contamination, and onerous regulations.

0 Comments

image: Ebola Update

Ebola Update

By | December 17, 2014

Plasma-based therapy trials begin in West Africa; NIH-GSK vaccine shows promise in Phase 1; the real statistics

0 Comments

image: Mining Existing Drugs for Ebola Treatments

Mining Existing Drugs for Ebola Treatments

By | December 17, 2014

Researchers hope to repurpose already-approved drugs into potential anti-Ebola therapies.

0 Comments

image: NIH Study Canceled

NIH Study Canceled

By | December 15, 2014

The National Institutes of Health shutters its initiative to track the health of 100,000 children through adulthood.

3 Comments

image: Ebola Update

Ebola Update

By | December 11, 2014

NIH admits new patient; joint pains stall clinical trial; U.S. grants immunity to vaccine developers; more

1 Comment

image: Ebola Vaccine Candidate Shows Promise

Ebola Vaccine Candidate Shows Promise

By | December 1, 2014

An experimental Ebola vaccine developed by the US National Institutes of Health appears to be safe and effective, according to a small, early-stage clinical trial.

0 Comments

image: Ebola Update

Ebola Update

By | November 26, 2014

Infection rates in Liberia decline; aid organizations struggle to procure gear; Merck enters the vaccine race; more

0 Comments

image: Mother’s Microbes Protect Baby’s Brain

Mother’s Microbes Protect Baby’s Brain

By | November 19, 2014

Bacteria in the gut of a pregnant mouse strengthen the blood-brain barrier of her developing fetus.

0 Comments

image: Week in Review: November 10–14

Week in Review: November 10–14

By | November 14, 2014

Funding for African science; microbiome studies may have contamination worries; mind-controlled gene expression; DNA record keeper

0 Comments

image: Ebola Drug Trials to Start in Africa

Ebola Drug Trials to Start in Africa

By | November 13, 2014

Researchers will test antiviral drugs and transfusions of blood from Ebola survivors in the West African countries hardest hit by the epidemic.

0 Comments

Advertisement
EMD Millipore
EMD Millipore

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  3. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

  4. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

Advertisement
Advertisement
Life Technologies